Fagron NV (EBR:FAGR)
19.10
-0.12 (-0.62%)
Mar 31, 2025, 11:19 AM CET
Fagron NV Revenue
In the year 2024, Fagron NV had annual revenue of 871.96M EUR with 14.28% growth. Fagron NV had revenue of 442.62M in the half year ending December 31, 2024, with 24.57% growth.
Revenue
871.96M
Revenue Growth
+14.28%
P/S Ratio
1.58
Revenue / Employee
227.78K
Employees
3,828
Market Cap
1.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 871.96M | 108.97M | 14.28% |
Dec 31, 2023 | 762.99M | 79.11M | 11.57% |
Dec 31, 2022 | 683.88M | 110.07M | 19.18% |
Dec 31, 2021 | 573.81M | 17.84M | 3.21% |
Dec 31, 2020 | 555.97M | 21.28M | 3.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
argenx SE | 2.17B |
UCB SA | 6.15B |
Financière de Tubize | 13.26K |
Ion Beam Applications | 465.75M |
Nyxoah | 4.52M |
Onward Medical | -188.00K |
Hyloris Pharmaceuticals | 10.04M |
Sequana Medical NV | 433.50K |
Fagron NV News
- 2 months ago - Fagron: FDA Warning Letter Creates New Entry Opportunity - Seeking Alpha
- 6 months ago - Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook - GlobeNewsWire
- 1 year ago - Record revenue of €209 million in first quarter reflecting 15% topline growth - GlobeNewsWire
- 1 year ago - Continued strong third quarter performance with 11% topline growth to €191 million - GlobeNewsWire
- 1 year ago - Fagron NV (ARSUF) Q2 2023 Earnings Call Transcript - Seeking Alpha